Leveraging a Clinico-Genomic Database to Match Patients to a Trial of Triciribine and Carboplatin: Changing Paradigms in Ovarian Cancer Clinical Research.

Trial Profile

Leveraging a Clinico-Genomic Database to Match Patients to a Trial of Triciribine and Carboplatin: Changing Paradigms in Ovarian Cancer Clinical Research.

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 17 Aug 2016

At a glance

  • Drugs Carboplatin (Primary) ; Triciribine (Primary)
  • Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Aug 2016 Planned number of patients changed from 45 to 36.
    • 06 Aug 2016 Planned End Date changed from 1 May 2016 to 1 Dec 2017.
    • 06 Aug 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Aug 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top